4
Changes in Ownership
Theriva Biologics, Inc. Filed Acc 0001144204-13-001056
CEO and President bought 2,900 shares at an average $0.17 ($506)
From the SEC's structured data for this filing
Trades in this filing
Riley Jeffrey Scott · CEO and President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-01-07 | Purchase : show line 1 in the form | +5 | $1.71 | $9 | 7,505 | D |
| 2013-01-07 | Purchase : show line 2 in the form | +2,895 | $0.17 | $498 | 10,400 | D |
| Open-market purchases · 2,900 sh · avg $0.17 · $506 | ||||||
Loading xslF345X03/v331583_4.xml…